Multicenter, Observational, Descriptive Study of the Diagnosis, Course and Treatment of Patients With SLE in Routine Practice in Kazakhstan: a Registry Study With Retrospective and Prospective Components.

Conditions: Description of SLE Activity in Patients in Routine Practice in the Republic of Kazakhstan, Description of the Course of SLE in Patients in the Republic of Kazakhstan, Description of Methods and Approaches to the Treatment of Patients With SLE in the Republic of Kazakhstan

Sex: All

Ages: 18 Years – N/A

Healthy volunteers: No

Enrollment: 509

Sponsor: AstraZeneca

Location: State Enterprise on the Right of Economic Management - Aktobe Medical Center Aktobe

Summary

Multicenter, observational, descriptive study of the diagnosis, course and treatment of patients with SLE in routine practice in Kazakhstan: a registry study with retrospective and prospective components.

Eligibility Criteria

Inclusion Criteria * Men and women aged 18 years and older with a verified diagnosis of SLE * Patient signed and dated written informed consent form (ICF) by ICH GCP and local legislation prior to inclusion in the study for the prospective observational group. Exclusion Criteria * Absence of a signed consent form (ICF) in patients * Cognitive impairments that hinder understanding the study objectives and completing questionnaires * Participation in any randomized controlled clinical trial within 3 months prior to inclusion or during participation in this study.

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT06899633). StuddyBuddy aggregates publicly available trial information.